Cover Page





      This book is dedicated to Adam.

      He knows why.

 

 

 

 

 

 

 

 

 

 

 

 

This title is also available as an e-book.
For more details, please see
www.wiley.com/buy/9781118759325
or scan this QR code:

 

logo

Clinical Investigations at a Glance




Jonathan Gleadle

MA, DPhil, BM, BCh, FRCP(UK), FRACP
Professor of Medicine
Flinders University
and Consultant Nephrologist
Flinders Medical Centre, Adelaide, Australia


Jordan Li

MBBS, FRACP
Senior Lecturer
Flinders University
and Consultant Physician
Flinders Medical Centre, Adelaide, Australia


Tuck Yong

MBBS, FRACP
Consultant Physician
Adelaide, Australia







Wiley Logo

Preface

We have written this book to try to improve the understanding of clinical investigations in medicine. It has arisen as a response to many students asking “What test should I do?” “What do I do about this incidental finding?” “Why was this test wrong?” Our patients asking “What is this test for?” “What does this test mean?” “Will it hurt?” And our medical colleagues referring patients with “The scan has shown a cyst, what do I do now?”

It was also written in part because of the growing recognition that many people are overdiagnosed, undergo too many tests and are overtreated for a wide range of conditions. There are a bewildering and growing array of tests that doctors can request in attempting to establish diagnosis and prognosis. Whilst many have provided powerful improvements in the accuracy of diagnosis, many carry with them the risk of incidental findings, significant cost and potential for harm. Understanding the role of such tests, their interpretation and how to deal with such asymptomatic discoveries is an increasing part of modern medical practice. Screening the general population for disease with tests is an increasingly difficult area and it is essential to consider whether patients are likely to benefit and whether any test will affect the patient’s outcome or management.

All clinical investigations are an adjunct to thorough clinical history and examination but not a substitute, and nor do they treat patients. Investigations should be ordered if they are of benefit in diagnosis, management, prevention and prognosis. This book is intended to assist clinicians develop evidence-based use of clinical investigations and interpret results of these investigations properly. We hope that this book will contribute to the better use of clinical investigations, improve diagnostic accuracy and reduce unnecessary tests or harm.

Jonathan Gleadle
Jordan Li
Tuck Yong

Acknowledgements

We are grateful to the many colleagues and students who have improved this book, provided images or edited the text and would particularly like to thank Elizabeth Johnston for helping to initiate this project.

We would like to thank the following for their expert reviews and provision of images.

Dr Marc Agazarian
Consultant Radiologist
Department of Medical Imaging
Flinders Medical Centre

Dr Justin Ardill
Consultant Cardiologist
Department of Cardiology
Flinders Medical Centre

Dr Virginia Au
Consultant Radiologist
Department of Medical Imaging
Flinders Medical Centre

Dr Jir-Ping Boey
Senior Registrar
Department of Haematology
Flinders Medical Centre

Dr Jeff Bowden
Consultant Respiratory Physician
Department of Respiratory and Sleep medicine
Flinders Medical Centre & Flinders University

Lynn Brown
Chief Cardiac Sonographer
Department of Cardiology
Flinders Medical Centre

Dr Joseph Frasca
Consultant Neurologist
Department of Neurology
Flinders Medical Centre

Ashley Gaw
Medical student
School of Medicine, Flinders University

Dr Zbigniew Gieroba
Consultant Geriatrician
Department of Aged Care
Flinders Medical Centre

Professor David Gordon
Consultant Infectious Disease Physician
Department of Microbiology & Infectious Diseases
Flinders Medical Centre & Flinders University

Lucy I-Ning Huang
Medical student
School of Medicine, Flinders University

Dr Neil Jones
Consultant Radiologist
Department of Medical Imaging
Flinders Medical Centre

Associate Professor Sonja Klebe
Consultant Surgical Pathologist
SA Pathology
Flinders Medical Centre & Flinders University

Dr Su Yin Lau
Senior Registrar
Department of Gastroenterology and Hepatology
Flinders Medical Centre

Jonathon Jing-Ping Liu
Medical student
School of Medicine, Flinders University

Dr Anand Rose
Consultant Respiratory Physician
Department of Respiratory and Sleep Medicine
Flinders Medical Centre & Flinders University

Dr Mark Siddins
Consultant Urologist
Flinders Private Hospital

Dr Magdalena Sobieraj-Teague
Consultant Haematologist
Department of Haematology and Genetic Pathology
Flinders Medical Centre & Flinders University

Dr Chrismin Tan
Senior Registrar
Department of Medical Imaging
Flinders Medical Centre

Dr Tilenka Thynne
Consultant Endocrinologist and Clinical Pharmacologist
Departments of Endocrinology and Clinical Pharmacology
Flinders Medical Centre & Flinders University

Dr Yew Toh Wong
Consultant Vascular Surgeon
Department of Vascular surgery
Flinders Medical Centre & Flinders University

Abbreviations

AAA
abdominal aortic aneurysm
ABG
arterial blood gas
ABI
ankle–brachial index
ACE
angiotensin converting enzyme
ACR
albumin : creatinine ratio
ACS
acute coronary syndrome
ADA
adenosine deaminase
ADH
antidiuretic hormone
AFB
acid-fast bacillus
AFP
α-fetoprotein
AHI
apnoea–hypopnoea index
AIDS
acquired immunodeficiency syndrome
AKI
acute kidney injury
AKP
alkaline phosphatase
ALT
alanine aminotransferase
ALP
alkaline phosphatase
AMI
acute myocardial infarction
AML
acute myeloid leukaemia
ANA
antinuclear antibody
ANCA
antineutrophil cytoplasmic antibody
Anti-CCP
anticyclic citrullinated peptide antibodies
APC
activated protein C
APS
antiphospholipid syndrome
APTT
activated partial thromboplastin time
AS
ankylosing spondylitis
AST
aspartate aminotransferase
AUC
area under the concentration curve
AVM
arteriovenous malformation
AXR
abdominal X-ray
BAEP
brainstem auditory evoked potential
BAL
bronchoalveolar lavage
BCC
basal cell carcinoma
BCG
bacillus Calmette–Guérin
β-hCG
beta subunit of human chorionic gonadotropin
BMC
bone mineral content
BMD
bone mineral density
BMI
body mass index
BNP
brain natriuretic peptide
BP
blood pressure
BPH
benign prostate hyperplasia
BPPV
benign positional paroxysmal vertigo
BGL
blood glucose level
C1-INH
C1 esterase inhibitor
CABG
coronary artery bypass grafting
CAD
coronary artery disease
CAP
community acquired pneumonia
CBD
common bile duct
CCF
congestive cardiac failure
CD
Crohn’s disease
CEA
carcinoembryonic antigen
CIDP
chronic inflammatory demyelinating polyneuropathy
CIN
contrast induced nephropathy
CK
creatine kinase
CKD
chronic kidney disease
CHL
conductive hearing loss
CLL
chronic lymphocytic leukaemia
CML
chronic myeloid leukaemia
CMR
cardiac magnetic resonance imaging
CMT
Charcot–Marie–Tooth (disease)
CMV
cytomegalovirus
CNS
central nervous system
COPD
chronic obstructive pulmonary disease
CPPD
calcium pyrophosphate deposition disease
CRBSI
catheter-related bloodstream infection
CRH
corticotropin-releasing hormone
CRC
colorectal cancer
CRP
C-reactive protein
CSA
central sleep apnoea
CSF
cerebrospinal fluid
CT
computed tomography
CTA
CT angiography
CTE
enteroclysis combined with CT
CTEPH
chronic thromboembolic pulmonary hypertension
CTG
cardiotocography
CTPA
computed tomography pulmonary angiography
CUP
cancer of unknown primary
CVP
central venous pressure
CXR
chest X-ray
DAT
direct antiglobulin test
DCIS
ductal carcinoma in situ
DcSSc
diffuse cutaneous scleroderma
DEXA
dual-energy X-ray absorptiometry
DHEA-S
dehydroepiandrosterone sulphate
DI
diabetes insipidus
DIC
disseminated intravascular coagulopathy
DIF
direct immunofluorescence
DIP
distal interphalangeal
DKA
diabetic ketoacidosis
DPL
diagnostic peritoneal lavage
DRE
digital rectal examination
DSA
digital subtraction angiography
ds-DNA
double-stranded DNA
DVT
deep vein thrombosis
DWI
diffusion-weighted imaging
EBV
Epstein–Barr virus
ECF
extracellular fluid
ECG
electrocardiogram
EDS
excessive daytime sleepiness
EEG
electroencephalogram
EF
ejection fraction
eGFR
estimated glomerular filtration rate
EGFR
epidermal growth factor receptor
EIA
enzyme immunoassay
ELISA
enzyme-based immunosorbent assay
EMG
electromyography
ENA
extractable nuclear antigen
EPS
electrophysiological study
ERCP
endoscopic retrograde cholangiopancreatography
ESR
erythrocyte sedimentation rate
EST
exercise stress test
ET
endotracheal
EUC
electrolytes, urea and creatinine
EUS
endoscopic ultrasound
FAI
free androgen index
FAST
focused abdominal sonography for trauma
FBC
full blood count
FDG
fluoro-2-deoxy-D-glucose
FEV1
forced expiratory volume in 1 second
FH
familial hypercholesterolaemia
FHH
familial hypocalciuric hypercalcaemia
FLAIR
fluid-attenuated inversion recovery
FLC
free light chain
FMD
fibromuscular dysplasia
FNA
fine-needle aspiration
FOBT
faecal occult blood test
FPG
fasting plasma glucose
FSGS
focal and segmental glomerulosclerosis
FSH
follicle-stimulating hormone
FT3
free triiodothyronine
FT4
free thyroxine
FTA-Abs
fluorescent treponemal antibody absorption
FVC
forced vital capacity
G6PD
glucose-6-phosphate dehydrogenase
GAT
granulocyte agglutination test
GBS
Guillain–Barré syndrome
GCA
giant cell arteritis
GCS
Glasgow coma scale
GFR
glomerular filtration rate
GGT
gamma glutamyl transferase
GH
growth hormone
GHRH
growth hormone releasing hormone
GI
gastrointestinal
GIFT
granulocyte immunofluorescence test
GORD
gastroesophageal reflux disease
GPA
granulomatosis with polyangiitis
GRA
glucocorticoid remediable hyperaldosteronism
H&E
haematoxylin and eosin
HAART
highly active antiretroviral therapy
HAE
hereditary angioedema
HAP
hospital-acquired pneumonia
Hb
haemoglobin
HCC
hepatocellular carcinoma
hCG
human chorionic gonadotrophin
HD
Huntington’s disease
HDL
high-density lipoprotein
HER
human epidermal growth factor receptor
HF
heart failure
HIT
heparin-induced thrombocytopenia
HIV
human immunodeficiency virus
HL
Hodgkin’s lymphoma
HPV
human papillomavirus
HRCT
high-resolution computed tomography
HRM
high-resolution manometry
HSV
herpes simplex virus
HUS
haemolytic uremic syndrome
IBD
inflammatory bowel disease
IBS
irritable bowel syndrome
ICT
immunochromatographic test
ICP
intracranial pressure
IDA
iron deficiency anaemia
IE
infective endocarditis
Ig
immunoglobulin
IGF
insulin-like growth factor
IGRA
interferon gamma release assay
IHD
ischaemic heart disease
IIF
indirect immunofluorescence assay
ILD
interstitial lung disease
INR
international normalised ratio
IPH
idiopathic pulmonary hypertension
IPI
International Prognostic Index
IPSS
International Prognostic Scoring System
ITP
immune thrombocytopenic purpura
ITT
insulin tolerance test
IUGR
intrauterine growth retardation
KCR
potassium : creatinine ratio
KUB
kidney, ureter and bladder (X-ray)
LBBB
left bundle branch block
LBO
large bowel obstruction
LBP
low back pain
LCR
ligase chain reaction
LcSSc
limited cutaneous scleroderma
LDH
lactate dehydrogenase
LDL
low-density lipoprotein
LFTs
liver function tests
LH
luteinising hormone
LP
lumbar puncture
LRTI
lower respiratory tract infection
LTBI
latent tuberculosis infection
MAHA
microangiopathic haemolytic anaemia
MCD
minimal change disease
MCP
metacarpophalangeal
MCS
microbiology culture and sensitivity
MCV
mean corpuscular volume
MDS
myelodysplastic syndromes
MELD
model for end-stage liver disease
MEN
multiple endocrine neoplasia
MGUS
monoclonal gammopathy of undetermined significance
MIBG
metaiodobenzylguanidine
MM
multiple myeloma
MMSE
mini-mental state examination
MPA
microscopic polyangiitis
MRA
magnetic resonance angiography
MRI
magnetic resonance imaging
MRSA
methicillin-resistant Staphylococcus aureus
MRV
magnetic resonance venography
MRCP
magnetic resonance cholangiopancreatography
MS
multiple sclerosis
MSCC
metastatic spinal cord compression
MTC
medullary thyroid cancer
NAAT
nucleic acid amplification test
NASH
non-alcoholic steatohepatitis
NCS
nerve conduction study
NHL
non-Hodgkin’s lymphoma
NPV
negative predictive value
NSAID
non-steroidal anti-inflammatory drug
OAE
oto-acoustic emission
OCT
optical coherence tomography
OGTT
oral glucose tolerance
OSA
obstructive sleep apnoea
PAD
peripheral arterial disease
PAH
pulmonary arterial hypertension
PAN
polyarteritis nodosa
pANCA
perinuclear antineutrophil cytoplasmic antibody
PAOP
pulmonary artery occlusion pressure
PAP
pulmonary artery pressure
PCOS
polycystic ovary syndrome
PCR
polymerase chain reaction; protein-to-creatinine ratio
PCV
packed cell volume
PDU
penile Doppler ultrasound
PE
pulmonary embolism
PEFR
peak expiratory flow rate
PET
positron emission tomography
PFT
pulmonary function test
PH
pulmonary hypertension
PHA
primary hyperaldosteronism
PID
pelvic inflammatory disease
PIP
proximal interphalangeal
PLED
paroxysmal lateral epileptiform discharge
PMR
polymyalgia rheumatica
PPI
proton pump inhibitor
PSA
prostate-specific antigen
PSG
polysomnography
PSI
pneumonia severity index
PT
prothrombin time
PTC
percutaneous transhepatic cholangiography
PTH
parathyroid hormone
PTHrP
PTH-related protein
PTLD
post-transplant lymphoproliferative disorders
PUD
peptic ulcer disease
PUO
pyrexia of unknown origin
PV
polycythaemia vera
PVD
peripheral vascular disease
RA
rheumatoid arthritis
RAS
renal artery stenosis
RBC
red blood cell
RCC
renal cell carcinoma
RDI
respiratory disturbance index
REM
rapid-eye movement
RF
rheumatoid factor
RLS
restless leg syndrome
RNS
repetitive nerve stimulation
RPR
rapid plasma reagin
RTA
renal tubular acidosis
SAAG
serum-ascites albumin gradient
SAH
subarachnoid haemorrhage
SBO
small bowel obstruction
SCC
squamous cell carcinoma
SFEMG
single-fibre electromyography
SHBG
sex hormone-binding globulin
SIADH
syndrome of inappropriate antidiuretic hormone secretion
SLE
systemic lupus erythematosus
SLN
sentinel lymph node
SLNB
sentinel lymph node biopsy
SNHL
sensorineural hearing loss
SOHL
sudden onset of hearing loss
SOT
solid organ transplant
SPECT
single-photon emission computed tomography
SPN
solitary pulmonary nodule
SSEP
somatosensory evoked potential
SSRI
selective serotonin reuptake inhibitor
STD
sexually transmitted disease
STEMI
ST elevation myocardial infarction
SUI
stress urinary incontinence
TB
tuberculosis
TCC
transitional cell carcinoma
TDM
therapeutic drug monitoring
TFT
thyroid function tests
TG
thyroglobulin
TIA
transient ischaemic attack
TIBC
total iron binding capacity
TLCO
carbon monoxide transfer factor
TOE
transoesophageal echocardiography
TPHA
treponema pallidum haemagglutination
TPO
thyroid peroxidase
TPPA
Treponema pallidum particle agglutination
TSH
thyroid-stimulating hormone
TST
tuberculin skin testing
TTE
transthoracic echocardiography
TTP
thrombotic thrombocytopenic purpura
UC
ulcerative colitis
UGI
upper gastrointestinal
UGB
upper gastrointestinal bleeding
USS
ultrasound scan
UTI
urinary tract infection
UUI
urgency urinary incontinence
VA
visual acuity
VATS
video-assisted thoracic surgery
VCE
video capsule endoscopy
VDRL
Venereal Disease Research Laboratory (test)
VEP
visual evoked potential
VHL
von Hippel–Lindau
V/Q
ventilation–perfusion
VRE
vancomycin-resistant enterococcus
VT
ventricular tachycardia
VTE
venous thromboembolism
VWD
von Willebrand disease
VWF
von Willebrand factor
VZV
varicella zoster virus
WBC
white blood cell
WHO
World Health Organization
WHR
waist-to-hip ratio
WPW
Wolff–Parkinson–White (syndrome)

Part 1 Overview of tests

Chapters

  1. 1 Investigations and interpreting tests
  2. 2 Screening tests
  3. 3 Consent for investigations
  4. 4 Risks of tests
  5. 5 Genetic tests
  6. 6 Principles of radiological investigations
  7. 7 Cytology and histopathology tests
  8. 8 Presenting at radiology and histopathology meetings
  9. 9 Requesting tests
  10. 10 Therapeutic drug monitoring
  11. 11 Investigations in resource-limited settings
  12. 12 Tests for outpatient, inpatient and patients in intensive care

1 Investigations and interpreting tests

Diagram shows blood tests, imaging, tests utilizing electrical activity, biopsies, urine analysis, genetic tests, and joint aspiration culture grew mycoplasma.

Investigations are tests to determine more about a person’s health, illness or prognosis. A variety of types of investigations can be undertaken, including: blood tests (e.g. biochemistry, haematology, immunology – Figure 1.1), radiology (e.g. plain X-rays, CT scans, ultrasounds, nuclear medicine tests, MRI scans – Figure 1.2), tests utilising electrical activity (e.g. ECG, EEG or nerve conduction – Figure 1.3), biopsies (tissue obtained for histological and cytological analysis – Figure 1.4), analysis of other biological fluids/specimens (e.g. urine, stool, cerebrospinal fluid – Figure 1.5), genetic testing (e.g. analysing for a DNA mutation that might cause disease – Figure 1.6) and tests for infection (e.g. attempts to culture an organism, detect DNA or an antibody response – Figure 1.7).

Investigations may be undertaken during an acute illness to contribute to making a diagnosis (e.g. a CT scan of the head in someone who is unconscious) or as a screening test in a well individual (e.g. a mammogram) to look for asymptomatic disease. Sometimes tests are undertaken to exclude particular diagnoses, especially if symptoms or signs of that illness can be subtle or nonspecific.

Prior to undertaking investigations in non-emergency settings, a detailed history and physical examination should be performed. Information obtained will often lead to selecting the most appropriate investigations.

When undertaking an investigation it is essential to ensure that it is done on the right person. Identification can be helped by accurate completion of request forms, verification of identity with questions about name, address, date of birth and examination of wrist bands. The use of sticky labels can improve the amount of information on a tube or a request form, but it is easy to mistakenly stick the wrong label on the wrong tube.

The person should have an appropriate understanding of the reason for the test, with consent that includes potential risks and consequences, the possible outcomes of the test and its implications.

The result

When requesting a test, consider how you (or other health professionals) will receive/check/chase the result and how the result will be communicated to the patient (and other relevant health professionals involved in care).

Confidentiality

Remember that all test results (and, indeed, even the fact that a patient is undergoing a test) should be regarded as confidential, restricted to the patient or professionals directly involved in their care and only shared with relatives and friends with the patient’s explicit permission and understanding. Similarly, test results and images should be stored in a confidential manner.

Repeating tests

In some situations it may be helpful to repeat a test; for example, when following change in an incidentally noted pulmonary nodule on CT scanning or repeating urea, creatinine and electrolytes to monitor response to rehydration. However, be wary of repeating tests too frequently or at too short an interval. Recognise that some abnormalities may take days or weeks to resolve following treatment and that the levels of some blood tests have prolonged half-lives. It is important to recognise that there will be variation in any test because of inter-individual variation and analytical variation.

Specificity and sensitivity

A perfect diagnostic test would be positive in every patient who has the disease (i.e. have no false negatives). This is the sensitivity of the test. The ideal test would also not be positive in any patient without the disease (i.e. have no false positives). This is the specificity. Diagnostic sensitivity is the proportion of individuals with disease who have a positive test associated with that disease. Diagnostic specificity refers to the proportion of individuals without disease who yield a negative test. A ‘perfect’ test would have both 100% diagnostic sensitivity and specificity. A test with 50% sensitivity and specificity is no better than tossing a coin.

For any test result one can compare the probability of getting that result if the patient truly had the condition with the probability if they were healthy. The ratio of these probabilities is the likelihood ratio (LR), calculated as sensitivity/(1 − specificity).

Receiver operator characteristic curves

A receiver operator characteristic curve plots the false-positive rate (FPR = 1 − specificity) versus the true-positive rate (TPR = sensitivity). They assess the diagnostic accuracy of any test. The area under the curve (range: 0.5–1.0) is a quantitative representation of test accuracy, where values from 0.5 to 0.7 represent low accuracy, from 0.7 to 0.9 represent tests that are useful for some purposes, and >0.9 represent tests with high accuracy.

Measures of disease probability

No test is perfect, and after every test the true disease state of the patient remains uncertain. Quantitating this residual uncertainty can be done with Bayes’ theorem. This provides a mathematical way to calculate the post-test probability of disease from three parameters: the pre-test probability of the disease, the test sensitivity and test specificity. Pre-test probability: can be estimated using population prevalence of disease or more patient-specific data.

numbered Display Equation

Normal range

When interpreting tests it is important to examine the test value with the normal range for that patient. These reference ranges are often derived from a population of ‘normal’ individuals and reflect the prediction interval within which 95% of values fall such that 2.5% of values will be less than the lower limit of this interval and 2.5% of the time it will be greater. However, this assumes a normal distribution of values and may not account for changes with age, gender and other physiological or pathological changes, such as impaired renal function. For some tests, because a large proportion of the ‘normal’ population have values associated with disease risk, a healthy or recommended range is quoted (e.g. vitamin D or cholesterol).

Incidental findings: none of us are ‘normal’

Incidental findings are results that you were not looking for. With increasingly sophisticated testing, very large number of healthy individuals can be found to have ‘abnormalities’ detected. Examples include benign cysts in the liver, detected with CT scans or ultrasounds, and small pulmonary nodules. The interpretation of such incidental findings can be difficult but should be grounded in the pre-test probability, any symptoms or signs and the incidence of such findings in healthy individuals.